RxDoctor Payments Data

Leonardo Brito de Almeida, MD

Neurology · Minneapolis, MNNPI 1013224427

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.4% of it on its own, with 2 other manufacturers making up the rest. Among neurology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$80,121in general payments, 2019–2025

Across 134 payments — averaging $597.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$53K
  • Boston Scientific$27K
  • Merz Pharmaceuticals, LLC$85
$251,288in research payments, 2019–2025

Across 40 payments — averaging $6282.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$207K
  • Abbott$45K

What the payments were for

  • Consulting fees$8,32510%
  • Speaking & faculty fees$47,52059%
  • Travel & lodging$20,29825%
  • Food & beverage$3,8935%
  • Education$850%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)114$53,215
Boston Scientific19$26,821
Merz Pharmaceuticals, LLC1$85

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,121 in reported general payments places this provider in the 95th percentile of 434 neurology providers in Minnesota.

See all neurology providers in Minnesota

Medicare billing

Part B allowed, 2024
$42,013
Medicare patients
101
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$88,419
RytaryCarbidopa/Levodopa49$62,252
Carbidopa-LevodopaCarbidopa/Levodopa226$14,463
Carbidopa14$3,563
Carbidopa-Levodopa ErCarbidopa/Levodopa45$2,836
Ropinirole ErRopinirole Hcl18$1,595
Gabapentin35$1,072
Primidone31$691
Propranolol Hcl26$639
Ropinirole Hcl14$493
AmantadineAmantadine Hcl17$424
Pregabalin17$189
Mirtazapine11$157
Topiramate13$153
Donepezil Hcl11$141

Paid to pharmacies, not to this prescriber.

Other neurology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →